Physician profile
Leena S Dev
NPI 1093725616
$1,897.04
in general payments reported to CMS, 2019-2025
20 companies · $232 in 2025
The $232 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $131 · 2021: $192 · 2022: $304 · 2023: $347 · 2024: $374 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.00 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $411.40 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Cranial Technologies, INC | $262.04 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $179.44 | 2019-2025 | Vaxneuvance, Vaxelis, Rotateq |
| Cumberland Pharmaceuticals, INC. | $164.65 | 2022-2023 | Kristalose |
| Ironshore Pharmaceuticals INC. | $160.03 | 2021-2024 | Jornay Pm |
| Sobi, INC | $159.39 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.39 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $72.70 | 2022-2024 | Flumist Quadrivalent |
| Kaleo, INC. | $66.24 | 2019-2021 | |
| Corium, LLC | $65.76 | 2023-2025 | Azstarys |
| Pfizer INC. | $61.20 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $34.30 | 2024 | |
| Sanofi Pasteur INC. | $34.24 | 2021-2024 | |
| Ars Pharmaceuticals Operations, INC. | $28.23 | 2025 | Neffy |
| Ultragenyx Pharmaceutical INC. | $21.94 | 2024 | Crysvita |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $21.81 | 2019 | |
| Tris Pharma INC | $21.35 | 2025 | Dyanavel Xr |
| Medline Industries LP | $21.19 | 2019 | |
| Seqirus USA INC | $17.83 | 2021 | |
| Phadia US INC. | $14.91 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leena Dev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.